Medicared For All Logo

Mark Karides in Chicago, Illinois

Home Illinois Chicago

Mark Karides has Hematology/oncology as his primary medical specialty. Their primary office is: 7447 W Talcott Ave in Chicago, Illinois.

They're a part of the: Illinois Cancer Specialists medical group which has around 31 members. You can call their office at 773-774-0042 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, his university is not listed and graduated in 1988 (around 36 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Mark Karides Office Phone and Directions

Mark Karides
Illinois Cancer Specialists
7447 W Talcott Ave
Chicago, Illinois 60631
773-774-0042

Patient Ratings
Please rate your experience with Mark Karides below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 773-774-0042


Enter a starting address:


Healthcare Info for Mark Karides

Medical School: Sorry, his university is not listed
Graduation Year: 1988
The Primary Medical Specialty for Mark Karides is listed as: Hematology/oncology
Approximate Years of Experience: 36
PAC (PECOS ID)#: 2264330844
NPI #: 1932206307
NPI Created On: 09/20/2006
NPI Last Updated Listed as: 12/17/2021
Primary Taxonomy Code: 207RH0003X
License Number:
036081870
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

  • Humana
  • Blue Cross Blue Shield
  • Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Spanish, Polish, Tagalog.

Services and Procedures include:

  1. Hydration infusion into a vein 31 minutes to 1 hour
  2. Hydration infusion into a vein
  3. Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
  4. Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
  5. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
  6. Injection of different drug or substance into a vein for therapy, diagnosis, or prevention
  7. Application of on-body injector for injection under skin
  8. Hormonal anti-neoplastic chemotherapy administration beneath the skin or into muscle
  9. Infusion of different chemotherapy drug or substance into a vein
  10. Infusion of chemotherapy into a vein up to 1 hour
  11. Infusion of chemotherapy into a vein
  12. Infusion of different chemotherapy drug or substance into a vein up to 1 hour
  13. Irrigation of implanted venous access drug delivery device
  14. New patient office or other outpatient visit, typically 45 minutes
  15. Established patient office or other outpatient, visit typically 25 minutes
  16. Established patient office or other outpatient, visit typically 40 minutes
  17. Initial hospital inpatient care, typically 50 minutes per day
  18. Initial hospital inpatient care, typically 70 minutes per day
  19. Subsequent hospital inpatient care, typically 25 minutes per day
  20. Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a

They took part in the Medicare Physician Quality Reporting System (PQRS).

They took part in the Million Hearts Initiative, which was deigned to improve cardiac outcomes.

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $25

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781011651

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $24

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781011653

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781011657

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $24

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781011655

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 795034115

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: VENCLEXTA

Open Associated Drug #1: 0074-0576-22

Payments Total: $18

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832179981

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: PADCEV

Open Associated Drug #1: 51144-030-01

Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832180111

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: TUKYSA

Open Associated Drug #1: 51144-001-60

Payments Total: $11

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783673599

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: ABECMA

Open Associated Drug #1: 59572-515-01

Payments Total: $20

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783417361

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: OPDIVO

Open Associated Drug #1: 0003-3774-12

Payments Total: $13

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783417365

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: OPDIVO

Open Associated Drug #1: 0003-3774-12

Hematology/oncology Professionals in Chicago

1.
Ira Oliff MD

7435 W Talcott Ave
Chicago, IL
Presence Healthcare Services

2.
Ira Oliff MD

2800 N Sheridan Rd
Chicago, IL
Presence Healthcare Services

3.
Sami Atassi MD

2600 S Michigan Ave
Chicago, IL

4.
Sami Atassi MD

1901 W Harrison St
Chicago, IL
Cook County

5.
Sylvia Falls

9831 S Western Ave
Chicago, IL
Advocate Health And Hospitals Corporation

6.
Adam Duvall

5841 S Maryland Ave
Chicago, IL
The University Of Chicago Medical Center

Providers in Illinois Cancer Specialists

1.Zachary Andor

1710 N Randall Rd
Elgin Il 60123-9405
Illinois Cancer Specialists
Physician Assistant

2.Zachary Andor

8915 W Golf Rd
Niles Il 60714-5905
Illinois Cancer Specialists
Physician Assistant

3.Lisa Baddi Do

7447 W Talcott Ave
Chicago Il 60631-3712
Illinois Cancer Specialists
Hematology/oncology

4.Sonia Christian

8915 W Golf Rd
Niles Il 60714-5905
Illinois Cancer Specialists
Hematology/oncology

5.Bety Ciobanu

7447 W Talcott Ave
Chicago Il 60631-3712
Illinois Cancer Specialists
Internal Medicine

6.Bety Ciobanu

8915 W Golf Rd
Niles Il 60714-5905
Illinois Cancer Specialists
Internal Medicine

View all 31 members of Illinois Cancer Specialists medical group


Medicared For All
Vote!
Share